Skip to main content

Ultrafiltration Patterns of Dextran and Hydroxyethylstarch during Long-Dwell Peritoneal Dialysis Exchanges in Nonuremic Rats

  • Chapter

Abstract

Commercially available peritoneal dialysis solutions contain glucose as an osmotic agent to obtain ultrafiltration (UF), but are associated with the disadvantage of rapid absorption.(1, 2) This results in loss of UF,(3, 4) and metabolic complications such as obesity and aggravation of lipid abnormalities.(5) Furthermore, low pH inhibits polymorphonuclear phagocytosis as does the high osmolality of the dialysate solution.(6) A slowly absorbable osmotic agent might be desirable, especially in patients with poor UF. Osmotic agent with larger molecules have longer duration of UF. Larger molecules would have to be present in high concentrations to achieve adequate osmotic effect, but would have the advantage of being more slowly absorbed. Recently, the advantages and disadvantages of several osmotic agents have been extensively reviewed.(7, 8)

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Kidney Int 1981; 19: 564–567.

    Article  PubMed  CAS  Google Scholar 

  2. Nolph KD, Twardowski ZJ, Popovich RP, Rubin J. J Lab Clin Med 1979; 93: 246–256.

    CAS  Google Scholar 

  3. Wideroe TE, Smeby LC, Mjaland S, Dahl K, Berg KJ, Aas TW. Nephron 1984; 38: 238–247.

    Article  PubMed  CAS  Google Scholar 

  4. Verger C. in: Khanna R, et al. (eds.): Advances in Continuous Ambulatory Peritoneal Dialsysis. Peritoneal Dialysis Bulletin, Toronto: 1985, pp. 87–95.

    Google Scholar 

  5. Gokal R, Ramos JM, McGurth JG, Ward MK, Kerr DNt in: Gahl GM, et al. (eds.): Advances in Peritoneal Dialysis. Excerpta Medica, Amsterdam: 1981, pp. 461–466.

    Google Scholar 

  6. Duwe AK, Vas SI, Weatherhead JW. infect Immun 1981; 33: 130–135.

    PubMed  CAS  Google Scholar 

  7. Twardowski ZJ, Khanna R, Nolph KD. Nephron 1986; 42: 93–101.

    Article  PubMed  CAS  Google Scholar 

  8. Hain H, Kessel M. Nephrol Dialysis Transpl 1987; 2: 67–72.

    CAS  Google Scholar 

  9. Laubenthal H, Peter K, Hedin H, Richter W, Meßmer K. Eur Surg Res 1981; 12 (Suppl l): 68–69.

    Google Scholar 

  10. F0rster H, Wicarcyk C, Dudziak R. Infusionstherapie 1981; 2: 88–94.

    Google Scholar 

  11. Khanna R, Mactier R, Twardowski ZJ, Nolph KD. Perit Dial Bull 1986; 3: 113–121.

    Google Scholar 

  12. Thoren L. Prog Clin Dial Res 1978; 19: 265–282.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Publishing Corporation

About this chapter

Cite this chapter

Hain, H., Kempf, D., Schnell, P., Gahl, G., Kessel, M. (1990). Ultrafiltration Patterns of Dextran and Hydroxyethylstarch during Long-Dwell Peritoneal Dialysis Exchanges in Nonuremic Rats. In: Avram, M.M., et al. Ambulatory Peritoneal Dialysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9555-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9555-7_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9557-1

  • Online ISBN: 978-1-4615-9555-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics